| Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection TW Chun, L Carruth, D Finzi, X Shen, JA DiGiuseppe, H Taylor, ... Nature 387 (6629), 183-188, 1997 | 2693 | 1997 |
| Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry MJ Borowitz, FE Craig, JA DiGiuseppe, AJ Illingworth, W Rosse, ... Cytometry Part B: Clinical Cytometry 78 (4), 211-230, 2010 | 532 | 2010 |
| Degradation of nuclear oncoproteins by the ubiquitin system in vitro. A Ciechanover, JA DIGIUsEPPE, B Bercovich, A Orian, JD Richter, ... Proceedings of the National Academy of Sciences 88 (1), 139-143, 1991 | 476 | 1991 |
| Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines ES Pizer, FJ Chrest, JA DiGiuseppe, WF Han Cancer research 58 (20), 4611-4615, 1998 | 335 | 1998 |
| Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. JA DiGiuseppe, WG Nelson, EJ Seifter, JK Boitnott, RB Mann Journal of Clinical Oncology 12 (12), 2573-2579, 1994 | 314 | 1994 |
| 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the … BL Wood, M Arroz, D Barnett, J DiGiuseppe, B Greig, SJ Kussick, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2007 | 313 | 2007 |
| Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms JD Day, JA Digiuseppe, C Yeo, M Lai-Goldman, SM Anderson, ... Human pathology 27 (2), 119-124, 1996 | 303 | 1996 |
| Overexpression of p53 protein in adenocarcinoma of the pancreas JA DiGiuseppe, RH Hruban, SN Goodman, M Polak, FM Van Den Berg, ... American journal of clinical pathology 101 (6), 684-688, 1994 | 294 | 1994 |
| Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy W Wang, JE Cortes, G Tang, JD Khoury, S Wang, CE Bueso-Ramos, ... Blood, The Journal of the American Society of Hematology 127 (22), 2742-2750, 2016 | 225 | 2016 |
| Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study JA DiGiuseppe, DC Louie, JE Williams, DT Miller, CA Griffin, RB Mann, ... The American journal of surgical pathology 21 (10), 1223-1230, 1997 | 224 | 1997 |
| Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study THM Keegan, SL Glaser, CA Clarke, ML Gulley, FE Craig, JA DiGiuseppe, ... Journal of Clinical Oncology 23 (30), 7604-7613, 2005 | 217 | 2005 |
| Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma JA DiGiuseppe, RH Hruban, GJ Offerhaus, MJ Clement, ... The American journal of pathology 144 (5), 889, 1994 | 180 | 1994 |
| p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma JA DiGiuseppe, MS Redston, CJ Yeo, SE Kern, RH Hruban The American journal of pathology 147 (4), 884, 1995 | 172 | 1995 |
| Population‐based patterns of human immunodeficiency virus‐related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998 SL Glaser, CA Clarke, ML Gulley, FE Craig, JA DiGiuseppe, RF Dorfman, ... Cancer 98 (2), 300-309, 2003 | 138 | 2003 |
| Hepatosplenic and subcutaneous panniculitis-like γ/δ T cell lymphomas are derived from different Vδ subsets of γ/δ T lymphocytes GK Przybylski, H Wu, WR Macon, J Finan, DGB Leonard, RE Felgar, ... The Journal of Molecular Diagnostics 2 (1), 11-19, 2000 | 130 | 2000 |
| Clinical utility of flow cytometry in the chronic lymphoid leukemias. JA DiGiuseppe, MJ Borowitz Seminars in oncology 25 (1), 6-10, 1998 | 129 | 1998 |
| Heterogeneity of Viral IL-6 Expression in HHV-8—Associated Diseases JS Cannon, J Nicholas, JM Orenstein, RB Mann, PG Murray, PJ Browning, ... The Journal of infectious diseases 180 (3), 824-828, 1999 | 126 | 1999 |
| Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. SL Cohn, H Salwen, MW Quasney, N Ikegaki, JM Cowan, CV Herst, ... Oncogene 5 (12), 1821-1827, 1990 | 120 | 1990 |
| Absence of Epstein‐Barr virus EBER‐1 transcripts in an epidemiologically diverse group of breast cancers SL Glaser, RF Ambinder, JA DiGiuseppe, PL Horn‐Ross, JL Hsu International journal of cancer 75 (4), 555-558, 1998 | 117 | 1998 |
| Increasing incidence of minimal residual cancer in radical prostatectomy specimens JA DiGiuseppe, J Sauvageot, JI Epstein The American journal of surgical pathology 21 (2), 174-178, 1997 | 107 | 1997 |
Richard F. AmbinderJohns Hopkins School of MedicineAdresse e-mail validée de jhmi.edu
